Contemporary OB/GYN week in review: musculoskeletal pain, STI care, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: musculoskeletal pain, STI care, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, April 29 - Friday, May 3 2024), and click each link to read and watch anything you may have missed.
1.) Study links premature menopause to musculoskeletal pain and sarcopenia risks
A recent study revealed an association between premature menopause and increased risks of musculoskeletal pain and sarcopenia, emphasizing the potential benefits of hormone therapy in mitigating long-term effects.
Click here for the full article.
2.) Learning what women prefer in STI preventive care
Jenell Stewart, DO, MPH, discusses her team's qualitative research into the STI prevention tendencies and interests of at-risk women
Click here for the full article.
3.) USPSTF releases new recommendations for breast cancer screenings
The United States Preventive Services Task Force has announced new recommendations for breast cancer screenings. Find out what this means for your patients and your practice.
Click here for the full article.
4.) Language barriers linked to worse gynecologic surgery pain management
A study highlighted how non-English-speaking patients undergoing gynecologic surgery face undertreated pain, emphasizing the need for equitable pain management practices.
Click here for the full article.
5.) Enhancing preeclampsia prediction with maternal cfDNA profiles
A recent investigation revealed how integrating maternal plasma cell-free DNA profiles significantly refines predictive accuracy in early- and late-onset preeclampsia.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
